Sunshine Biopharma Stock Forecast

Sell candidate since Jul 31, 2026

The Sunshine Biopharma, Inc. stock price fell by -27.91% on the last day (Friday, 31st Jul 2026) from $0.0430 to $0.0310. During the last trading day the stock fluctuated 683.23% from a day low at $0.0310 to a day high of $0.243. The price has fallen in 4 of the last 10 days and is down by -11.17% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 thousand shares and in total, 173 shares were bought and sold for approximately $5.36 .

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock.

SBFMW Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Sunshine Biopharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.0531 and $0.0488. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, June 23, 2026, and so far it has fallen -65.52%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Sunshine Biopharma, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0288 and $0.0280. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Sunshine Biopharma, Inc. finds support just below today's level at $0.0288. If this is broken, then the next support from accumulated volume will be at $0.0280 and $0.0250.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.212 between high and low, or 683.23%. For the last week the stock has had daily average volatility of 310.31%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SBFMW) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Sunshine Biopharma, Inc. to open at $0.102, and during the day (based on 14 day Average True Range), to move between $0 and $0.0765, which gives a possible trading interval of +/-$0.0910 (+/-76 510.06%) up or down from last closing price. If Sunshine Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 76 510.06% move between the lowest and the highest trading price during the day. ⚠️ Extreme Volatility Warning: The projected daily trading range exceeds 1000%, indicating exceptionally high volatility. This level of price movement suggests significant market uncertainty and elevated risk. Traders should exercise extreme caution, consider reduced position sizes, and implement strict risk management strategies when trading this security.

Since the stock is closer to the resistance from accumulated volume at $0.0322 (3.87%) than the support at $0.0288 (7.10%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Sunshine Biopharma, Inc. stock A Buy?

Sunshine Biopharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -3.154 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $0.102 ( 227.74%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk